CLINICAL_TRIALS
trial_result
· 2020-06-02
Clinical Trial Update: A Study to Evaluate the Safety and Clinical Study of Azelaic Acid Gel 15% in Patients With Moderate Facial Rosacea [Phase 3]
Summary
A Phase 3 trial evaluated the safety and clinical outcomes of azelaic acid gel 15% for moderate facial rosacea; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Actavis Inc. | Conditions: Rosacea | Phase 3 | Status: COMPLETED | Results posted: 2020-06-02